Page 32 - டேவிட் பால் மோரிஸ் ப்ளூம்பெர்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

J&J Pause Risks Hesitancy Even as U.S. Sees Ample Shots Bloomberg 21 mins ago Josh Wingrove and Angelica LaVito © Photographer: David Paul Morris/Bloomberg Healthcare workers wearing protective masks administer doses of the Johnson & Johnson Janssen Covid-19 vaccine to senior residents at San Rafael Commons in San Rafael, California. (Bloomberg) Johnson & Johnson’s Covid-19 vaccine represents only a sliver of the current U.S. supply, but pausing its use could present new hurdles for an immunization campaign that needs to overcome wider vaccine hesitancy to outpace fast-spreading variants. Popular Searches The U.S. Centers for Disease Control and Prevention and Food and Drug Administration said on Tuesday in a joint statement that they would pause use of the J&J shot after six women who received it developed a rare and severe form of blood clotting. The FDA signaled the pause would last a matter of days.

United statesWhite houseDistrict of columbiaJeff zientsRafael commonsDavid paul morris bloombergJoe bidenJohnson janssen covidUs centers for diseaseDrug administrationAstrazeneca plcWalgreens boots alliance incHealth corpPfizer incModerna incJohnson janssen